tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

GB:HCM Stock Latest News

HUTCHMED Files New SEC Registration Statement
Company AnnouncementsHUTCHMED Files New SEC Registration Statement
5d ago
HUTCHMED Announces Voting Rights and Global Focus
PremiumCompany Announcements
HUTCHMED Announces Voting Rights and Global Focus
5d ago
HUTCHMED Schedules 2024 Mid-Year Results Review
PremiumCompany Announcements
HUTCHMED Schedules 2024 Mid-Year Results Review
7d ago
HUTCHMED to Announce 2024 Half-Year Financial Results
PremiumPress Releases
HUTCHMED to Announce 2024 Half-Year Financial Results
7d ago
HCM
HUTCHMED Announces Upcoming R&D Event and Webinar
PremiumCompany Announcements
HUTCHMED Announces Upcoming R&D Event and Webinar
9d ago
Save the Date: HUTCHMED to Present R&D Updates on July 9, 2024
PremiumPress ReleasesSave the Date: HUTCHMED to Present R&D Updates on July 9, 2024
9d ago
HCM
HUTCHMED’s Fruquintinib Wins EU Approval for Colorectal Cancer
PremiumCompany Announcements
HUTCHMED’s Fruquintinib Wins EU Approval for Colorectal Cancer
10d ago
HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda
PremiumPress Releases
HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda
12d ago
HCM
HUTCHMED’s Sovleplenib Shows Promise for ITP
PremiumCompany Announcements
HUTCHMED’s Sovleplenib Shows Promise for ITP
17d ago
HUTCHMED Highlights Publication of Phase III ESLIM-01 Results in The Lancet Haematology
PremiumPress Releases
HUTCHMED Highlights Publication of Phase III ESLIM-01 Results in The Lancet Haematology
17d ago
HCM
HUTCHMED Tests New Leukemia Drug in Phase I Trial
PremiumCompany Announcements
HUTCHMED Tests New Leukemia Drug in Phase I Trial
27d ago
HUTCHMED Initiates Phase I Trial of Menin Inhibitor HMPL-506 in Patients with Hematological Malignancies in China
PremiumPress Releases
HUTCHMED Initiates Phase I Trial of Menin Inhibitor HMPL-506 in Patients with Hematological Malignancies in China
27d ago
HCM
Hutchmed announces FRUTIGA results published in Nature Medicine
PremiumThe FlyHutchmed announces FRUTIGA results published in Nature Medicine
1M ago
HCM
HUTCHMED’s Fruquintinib Shows Promise for Gastric Cancer
PremiumCompany Announcements
HUTCHMED’s Fruquintinib Shows Promise for Gastric Cancer
1M ago
HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
PremiumPress Releases
HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
1M ago
HCM
HUTCHMED Shares Update & Company Innovations
PremiumCompany Announcements
HUTCHMED Shares Update & Company Innovations
1M ago
Hutchmed initiated with a Buy at HSBC
PremiumThe Fly
Hutchmed initiated with a Buy at HSBC
1M ago
HCM
HUTCHMED Unveils Promising Cancer Drug Studies at ASCO 2024
PremiumCompany Announcements
HUTCHMED Unveils Promising Cancer Drug Studies at ASCO 2024
1M ago
HUTCHMED Highlights Presentations at the 2024 ASCO Annual Meeting
PremiumPress Releases
HUTCHMED Highlights Presentations at the 2024 ASCO Annual Meeting
1M ago
HCM
HUTCHMED Appoints New Chairman Amid Board Changes
PremiumCompany AnnouncementsHUTCHMED Appoints New Chairman Amid Board Changes
2M ago
HUTCHMED announces retirement of Chairman, appointment of new Chairman and change of members of board committees
PremiumPress Releases
HUTCHMED announces retirement of Chairman, appointment of new Chairman and change of members of board committees
2M ago
HCM
Hutchmed chairman Simon To retires, Dan Eldar to succeed
PremiumThe Fly
Hutchmed chairman Simon To retires, Dan Eldar to succeed
2M ago
HCM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >